🛑𝗜𝘁’𝘀 𝗪𝗼𝗿𝗹𝗱 𝗔𝗻𝘁𝗶𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗮𝗹 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗪𝗲𝗲𝗸.

Antimicrobial resistance (𝗔𝗠𝗥) is not a distant threat — it’s happening today and the data speaks volumes.

𝗦𝘄𝗶𝗽𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 to see the staggering 𝗶𝗺𝗽𝗮𝗰𝘁 of antimicrobial drug resistance, particularly on 𝗰𝗮𝗻𝗰𝗲𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀.

𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿, we must strengthen awareness, stewardship, and innovation to preserve the effectiveness of antibiotics — and the future of global health.

At the upcoming 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗲𝗽𝘀𝗶𝘀 𝗔𝗹𝗹𝗶𝗮𝗻𝗰𝗲 𝗪𝗲𝗯𝗶𝗻𝗮𝗿, Dr. Diego Lopez Mendoza, MD from Menarini Group will discuss the impact of AMR on cancer outcomes and share key recommendations — from investing in rapid diagnostics to fostering collaboration between oncology and infectious disease experts.

WHO Director-General Dr Tedros Antimicrobial Resistance occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents. As a result of drug resistance, antibiotics and other antimicrobial agents become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness and death. The World AMR Awareness Week (WAAW) is a global campaign to raise awareness and increase understanding of AMR and to promote global action to tackle the emergence and spread of drug-resistant pathogens. As one of WHO’s official health campaigns, WAAW is mandated by the World Health Assembly and is commemorated annually from 18 to 24 November.

WHO Director-General Dr Tedros Antimicrobial Resistance occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents. As a result of drug resistance, antibiotics and other antimicrobial agents become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness and death. The World AMR Awareness Week (WAAW) is a global campaign to raise awareness and increase understanding of AMR and to promote global action to tackle the emergence and spread of drug-resistant pathogens. As one of WHO’s official health campaigns, WAAW is mandated by the World Health Assembly and is commemorated annually from 18 to 24 November.

European Antibiotic Awareness Day (EAAD) provides a platform to support for national campaigns on the prudent use of antibiotics. Each year, EAAD, which is coordinated by the European Centre for Disease Prevention and Control (ECDC), is marked across Europe by national campaigns on or around 18 November. EAAD is a European health initiative, acknowledging the growing problem with antimicrobial resistance, and recognising the need to raise awareness on the prudent use of antibiotics in human and veterinary medicine in order to curb antibiotic resistance. As a result of collaboration with the World Health Organization’s Regional Office for Europe and other European and international partners, what started out as a small initiative in 2008, providing a platform for national campaigns in the European Union/European Economic Area (EU/EEA), has grown over the years to become an important event which is marked in more than 43 countries.

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue of the CDTR covers the period 6-12 December 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, measles, Middle East respiratory syndrome (MERS-CoV), West Nile virus, and Marburg virus disease (MVD).